ScoreWhy is Citius Pharmaceuticals, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
- INTEREST(9M) At USD 0.28 MM has Grown at inf%
- OPERATING CASH FLOW(Y) Lowest at USD -31.6 MM
- ROCE(HY) Lowest at -75.61%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -40.13%, its profits have risen by 4%
3
Below par performance in long term as well as near term
- Along with generating -40.13% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Citius Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Citius Pharmaceuticals, Inc.
-40.13%
-0.90
106.94%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
37.64%
EBIT Growth (5y)
-24.29%
EBIT to Interest (avg)
-33.14
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.05
Tax Ratio
1.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.78%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.20
EV to EBIT
-0.25
EV to EBITDA
-0.26
EV to Capital Employed
0.13
EV to Sales
2.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-51.11%
ROE (Latest)
-48.59%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
NET PROFIT(HY)
Higher at USD -29.45 MM
NET SALES(9M)
Higher at USD 5.61 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 0.19 times
DEBTORS TURNOVER RATIO(HY)
Highest at 10.4 times
-21What is not working for the Company
INTEREST(9M)
At USD 0.28 MM has Grown at inf%
OPERATING CASH FLOW(Y)
Lowest at USD -31.6 MM
ROCE(HY)
Lowest at -75.61%
RAW MATERIAL COST(Y)
Grown by 2,290% (YoY
OPERATING PROFIT(Q)
Lowest at USD -30.43 MM
PRE-TAX PROFIT(Q)
Lowest at USD -28.34 MM
NET PROFIT(Q)
Lowest at USD -21.23 MM
Here's what is working for Citius Pharmaceuticals, Inc.
Net Sales
At USD 5.61 MM has Grown at inf%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Inventory Turnover Ratio
Highest at 0.19 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 10.4 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Higher at USD 5.61 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Depreciation
Highest at USD 1.76 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Depreciation
At USD 1.76 MM has Grown at 216.18%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (USD MM)
Here's what is not working for Citius Pharmaceuticals, Inc.
Interest
At USD 0.28 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Pre-Tax Profit
At USD -28.34 MM has Fallen at -151.98%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -21.23 MM has Fallen at -94.49%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -31.6 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Operating Profit
Lowest at USD -30.43 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -28.34 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -21.23 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Raw Material Cost
Grown by 2,290% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
